# Topical Pentoxifylline; Metformin Versus Betamethasone in the Treatment of Alopecia Areata.

> **NCT06087796** · PHASE1 · UNKNOWN · sponsor: **Assiut University** · enrollment: 60 (estimated)

## Conditions studied

- Alopecia Areata

## Interventions

- **DRUG:** Betamethasone Valerate 0.1% Cream
- **DRUG:** Pentoxifylline
- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT06087796
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-10
- **Primary completion:** 2024-09
- **Final completion:** 2024-10
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2023-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06087796

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06087796, "Topical Pentoxifylline; Metformin Versus Betamethasone in the Treatment of Alopecia Areata.". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT06087796. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*